Desmopressin intranasal ( DrugBank: Desmopressin )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 72 | 下垂体性ADH分泌異常症 | 1 |
72. 下垂体性ADH分泌異常症
臨床試験数 : 40 / 薬物数 : 28 - (DrugBank : 7) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 9
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01280188 (ClinicalTrials.gov) | January 2011 | 19/1/2011 | A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI). | Peroral Administration of Different Doses of Desmopressin Administered as a New Orally-Disintegrating Tablet and Desmopressin for Nasal Administration in the Treatment of CDI in Japanese Patients | Central Diabetes Insipidus | Drug: Desmopressin Oral Melt;Drug: Desmopressin intranasal | Ferring Pharmaceuticals | NULL | Completed | 6 Years | 75 Years | Both | 20 | Phase 3 | Japan |